|
市場調査レポート
商品コード
1276388
リパーゼ食品酵素の世界市場規模、シェア、産業動向分析レポート:用途別(飲食品加工、動物飼料、その他)、形態別(粉末、液体)、供給源別、地域別展望と予測、2023~2029年Global Lipase Food Enzymes Market Size, Share & Industry Trends Analysis Report By Application (Food & Beverage Processing, Animal Feed, and Others), By Form (Powder and Liquid), By Source, By Regional Outlook and Forecast, 2023 - 2029 |
||||||
リパーゼ食品酵素の世界市場規模、シェア、産業動向分析レポート:用途別(飲食品加工、動物飼料、その他)、形態別(粉末、液体)、供給源別、地域別展望と予測、2023~2029年 |
出版日: 2023年04月28日
発行: KBV Research
ページ情報: 英文 233 Pages
納期: 即納可能
|
リパーゼ食品酵素市場規模は、2029年には6億7,950万米ドルに達すると予測され、予測期間中のCAGRは6.9%の市場成長で上昇すると予想されています。
理想的な乳化剤の代用品は、食品酵素のリパーゼであると考えられています。リパーゼによって脂質が脂肪酸とグリセロールに分解されると、パンやケーキなどの焼き菓子に含まれる脂肪の量がさらに減少します。また、リパーゼは乳化剤の性質も発揮します。乳製品、菓子類、ベーカリーなどでは、乳化剤の代わりに食物酵素を使用することができ、市場の成長を後押しする可能性があります。
消化の観点からは、リパーゼとアミラーゼは消化器系の効率的な運用に絶対必要なものです。これらは、脂質の消化を助け、炭水化物の分解を助ける。リパーゼは消化器系の重要な構成要素であるため、正常な範囲内に維持することが重要です。消化を助けるだけでなく、膵臓酵素であるリパーゼは、食事から体の他の部位への脂肪の輸送を促進します。その結果、予測期間中にリパーゼの需要が増加する可能性があります。
COVID-19の影響分析
パンデミックの影響で、食品業界では消費者の需要を満たすのに苦労し、収入が減少しました。いくつかの企業が一時的に閉鎖されたことは、さまざまな産業が世界に互いに密接に関連していることを例証しています。従業員の健康を守り、病気やCOVID感染を恐れて出勤を控える従業員を確保することは、すべての食品産業に共通する大きな悩みでした。そのため、リパーゼの工業的用途が増える一方で、食品業界ではその性能の低さから需要が減少しました。しかし,健康的な食品に対する意識が高まると,リパーゼの需要にプラスの影響を与えました。このように、パンデミックは市場に中程度の影響を及ぼしました。
マーキーの成長要因
さまざまな産業におけるリパーゼ酵素の数多くのアプリケーション
リパーゼ酵素は、医療や診断目的でも活用されています。リパーゼ酵素は、血液検査を通じて、急性膵炎やその他の消化器系疾患の診断を助けることができます。さらに、リパーゼ酵素は、脂肪を脂質に分解することで、膵臓酵素補充療法(PERT)を受ける患者をサポートします。リパーゼ酵素の需要を後押しする主な理由は、加工食品や食肉の消費量の増加、動物の健康に対する意識の高まりです。これらの要素を考慮すると、リパーゼ食品酵素市場の価値と数量は今後数年間で増加すると予想されます。
バイオセンサー技術の活用
方向づけられた進化は、業界にとって重要なリパーゼの特性を高めることができます。リパーゼのバイオテクノロジーの応用としては、エナンチオピュア医薬品、フレーバー化合物、天然ポリマー、バイオディーゼルの製造が成功しました。生成された食品酵素の使用目的の適切性という点では、世界市場では多数の小規模生産者が市場関係者と競合しています。これは、逆に言えば、生産者が作り出す生産菌株の資質に依存することになります。さらに、いくつかの技術ライセンシーが、小規模生産者が膨大な数を生産するために拡張できるプログラマブルな酵素を作成できるようにしています。このような要素が、市場の拡大に寄与しているのです。
市場の抑制要因
限られた温度とpHの範囲で動作すること
身近な環境要因は、食品酵素の動作に大きく影響します。熱による攪拌は食品酵素を分解して機能させないが、温度が下がると反応速度が急激に低下します。また、食品酵素の機能範囲外でpHを変化させると、酵素の活性が低下し、最終的には永久変性に至る可能性があります。食品酵素の生産者は、幅広い温度とpHで機能する酵素の開発に取り組んでいますが、酵素の利用を飲食品の製造工程のすべてのステップに組み込むには、まだ多くの課題が残っています。そのため、リパーゼの使用に伴うこうした制約が、市場の成長を制限する可能性があります。
ソース別の展望
リパーゼ食品酵素市場は、供給源に基づき、微生物、動物、植物に分類されます。微生物セグメントは、2022年のリパーゼ食品酵素リパーゼ食品酵素市場で最も高い収益シェアを獲得しました。多数の追加工業製品の中で、微生物によって生産されるリパーゼ食品酵素は、洗剤、加工食品、医薬品、およびバイオ燃料の生産に採用されています。微生物は生理、生態、代謝の面で非常に安定しており、特殊であるため、高温、厳しいpHレベル、有機溶媒などの厳しい環境下でも機能することができます。
形態の展望
リパーゼ食品酵素市場は、形態によって粉末と液体に分類されます。2022年のリパーゼ食品酵素市場では、液体セグメントが大きな収益シェアを記録しました。乳脂肪はリパーゼを使用して加水分解されるが、このプロセスでは一般的に液体で採用されるため、液体リパーゼは他の形態の酵素よりも好まれます。フレーバーエンハンサーやコーヒーのホワイトニング剤などはともかく、その大半は液状で使用されています。液体リパーゼを飲料に加えたり、直接経口摂取したりするのは簡単です。薬を飲み込むのが苦手な人がいれば、リパーゼを栄養補助食品として使うのは魅力的な選択肢かもしれません。液体リパーゼのサプリメントにはスポイトが付属していることが多いので、正確に服用することができます。
アプリケーションの展望
リパーゼ食品酵素市場は、用途別に飲食品加工、動物飼料、その他に分類されます。2022年のリパーゼ食品酵素市場では、食品・飲料加工分野が最大の収益シェアとなりました。食品および飲料の用途には、肉、乳製品、ベーカリー、栄養補助食品の加工や、追加食品(加工食品、植物油加工、果物&野菜加工など)が含まれます。また、ペプチドやアミノ酸は、野菜や酵母のタンパク質を酵素で加水分解するなどの工程で生成され、缶詰、冷凍食品、調理済み食品の風味付けとして機能します。これらの理由により、食品産業における酵素の需要は拡大しています。
地域別の展望
地域別に見ると、リパーゼ食品酵素市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米セグメントは、2022年のリパーゼ食品酵素市場において最大の収益シェアを記録しました。北米の市場は、加工食品やコンビニエンスフードの需要の増加、酵素で強化された食品を食べることによる健康効果に対する意識の高まり、リパーゼ酵素の新規アプリケーションや配合の開拓など、いくつかの要因によって牽引されています。リパーゼ食品酵素の主な市場拡大勢力は、米国とカナダです。
List of Figures
The Global Lipase Food Enzymes Market size is expected to reach $679.5 Million by 2029, rising at a market growth of 6.9% CAGR during the forecast period.
The breakdown of oils and fats into their more basic components, like fatty acids and glycerol, is accelerated by food enzymes called lipases. The human body and many different microorganisms, including bacteria, yeast, and fungi, naturally contain these enzymes. As a result, the food industry commonly uses lipase enzymes as an addition to create a variety of food products. For example, they can be applied to food goods to improve their flavor, texture, and nutritional value, as well as to extend their shelf life.
Food enzymes offer various functional qualities and can emulsify various food components. Food items benefit from food enzymes in a manner similar to how emulsifiers are used to boost the kinetic stability of food. Food enzymes have a significant advantage over emulsifiers in that they are classified as clean-label ingredients. The need for food enzymes is expanding globally as the rules governing the use of labeled additives become more stringent.
The ideal emulsifier substitute is thought to be the food enzyme lipase. When lipids are broken down into fatty acids and glycerol by lipase, the amount of fat in baked goods like bread and cakes is further decreased. Lipase also exhibits the qualities of emulsifiers. Food enzymes can be used in place of emulsifiers in dairy, confectionery, bakery, and other industries, which has the potential to boost the market growth.
From the perspective of digestion, lipase and amylase are absolutely necessary for the efficient operation of the digestive system. These aid in the digestion of lipids and aid in the breakdown of carbohydrates. Maintaining lipase within the normal range is vital because it is such a crucial component of the digestive system. In addition to aiding in digestion, the pancreatic enzyme lipase facilitates the transport of fats from the meal to other regions of the body. As a result, there is potential for an increase in demand for lipase during the forecasted time period.
COVID-19 Impact Analysis
Organizations in the food industry struggled to fulfill consumer demand, and income declined amid the pandemic. The temporary closure of some businesses exemplified how closely related various industries are to one another globally. Protecting employee health and maintaining worker accessibility owing to illness or workers refusing to report to work due to the fear of COVID infection was a major worry shared by all food organizations. Therefore, while the industrial uses of lipase increased, its demand decreased in the food industry because of its negative performance. However, as the awareness about healthy food increased, it affected the lipase demand positively. Thus, the pandemic had a moderate impact on the market.
Markey Growth Factors
Numerous applications of lipase enzyme across various industries
Lipase enzymes are also utilized in medicine and for diagnostic purposes. Lipase enzymes can aid in the diagnosis of acute pancreatitis along with other gastrointestinal diseases in people through blood testing. In addition, lipase enzymes help patients receive pancreatic enzyme replacement therapy (PERT) by breaking down fats into lipids. The primary reasons propelling the lipase enzyme demand are the rising consumption of processed foods and meat and increased awareness of animal health. In light of these elements, it is anticipated that the value and volume of the lipase food enzymes market will increase in the coming years.
The use of biosensor technology
Directed evolution can enhance the characteristics of lipases that are important to the industry. Successful biotechnological applications of lipases include the manufacture of enantiopure medicines, flavor compounds, natural polymers, and biodiesel. In terms of the intended use appropriateness of the food enzymes generated, there are numerous small-scale producers competing with the market players in the world market. This, in turn, relies on the caliber of the producing strain created by producers. In addition, several technology licensees allow small-scale producers to create programmable enzymes that can be expanded to produce huge numbers. These kinds of elements are contributing to the expansion of the market.
Market Restraining Factors
Operating at a limited range of temperatures and pH
Environmental factors in the immediate surroundings greatly impact how food enzymes operate. While thermal agitation breaks down the food enzyme, rendering it non-functional, a drop in temperature results in a sharp reduction in the reaction rate. Altering the pH outside the food enzyme's functional range also decreases the enzyme's activity and may eventually result in permanent denaturation. Although producers of food enzymes are working to create enzymes that can function in a wide range of temperatures and pH levels, there remains plenty of work to do before enzyme utilization is incorporated into every step of the manufacturing process for food and beverages. Therefore, these limitations associated with using lipase may restrict the market's growth.
Source Outlook
Based on source, the lipase food enzymes market is characterized into microorganisms, animals, and plants. The microorganisms segment garnered the highest revenue share in the lipase food enzymes lipase food enzymes market in 2022. Among numerous additional industrial products, lipase food enzymes produced by microorganisms are employed in the production of detergents, processed foods, pharmaceuticals, and biofuels. Because they are very stable and specialized in terms of physiology, ecology, and metabolism, the microorganisms can function in tough environmental circumstances like high temperatures, harsh pH levels, and organic solvents.
Form Outlook
On the basis of form, the lipase food enzymes market is classified into powder and liquid. The liquid segment recorded a significant revenue share in the lipase food enzymes market in 2022. Since milk fat is hydrolyzed using lipase, which is typically employed in liquid form in this process, liquid lipase is preferred over other forms of the enzyme. The majority of these are used in liquid form, whether they are flavor enhancers or coffee whiteners, aside from that. Adding liquid lipase to beverages or taking it orally directly is simple. If someone has trouble swallowing medications, using lipase as a dietary supplement may be an attractive option. The dropper frequently included with liquid lipase supplements makes accurate dosing possible.
Application Outlook
By application, the lipase food enzymes market is divided into food & beverage processing, animal feed, and others. The food & beverage processing segment witnessed the maximum revenue share in the lipase food enzymes market in 2022. The food and beverage applications include processing meat, dairy, bakery, and nutraceuticals, as well as additional food products (like processed food, vegetable oil processing, and processed fruits & vegetables). In addition, peptides and amino acids are produced by processes such as the enzymatic hydrolysis of vegetable and yeast proteins and operate as flavor enhancers in canned, frozen, and ready-to-eat food products. These reasons have led to a growing demand for enzymes in the food industry.
Regional Outlook
Region wise, the lipase food enzymes market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the lipase food enzymes market in 2022. The market in North America is being driven by several factors, including increased demand for processed and convenience foods, a growing awareness of the health benefits of eating foods enhanced by enzymes, and the development of novel applications and formulations for lipase enzymes. The main market expansion forces for lipase food enzymes are in the United States and Canada.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Chr. Hansen Holding A/S, Associated British Foods PLC (Wittington Investments Limited), Biocatalysts Limited (Brain Biotech AG), Novozymes A/S (Novo Holdings A/S), BASF SE, Infinita Biotech Private Limited, Antozyme Biotech Pvt Ltd, Jiangsu Yiming Biological Technology Co., Ltd., Creative Enzymes and Enzyme Development Corporation.
Strategies Deployed in Lipase Food Enzymes Market
Mar-2023: Biocatalysts Ltd unveiled Nuclease 46L (N046L), an enzyme helpful in the degradation of diverse nucleic acids extracted from a wide range of sources. Nuclease 46L (N046L) would be an affordable solution beneficial in removing DNA from a broad range of biotechnology applications.
Feb-2023: Chr. Hansen's received three EU approvals for HMOs lacto-N-tetraose (LNT), 3-fucosyllactose (3-FL) and 3'-sialyllactose (3'-SL), the three Human Milk Oligosaccharides and are declared as safe infant formula. With these approvals, now mothers would be able to feed their infants who cannot be breastfed. The new offerings with HMOs in concentration would empower Chr. Hansen's to deliver 5 HMO Mix into infant formula.
Feb-2023: AB Enzymes, a subsidiary of Associated British Foods PLC, and Barentz International, a life science ingredients distributor, came into a distribution agreement to boost AB Enzymes' position in delivering bake & food enzymes offerings in Europe. With this agreement, Barentz's expertise in supplying human nutrition would enable AB Enzymes in distributing AB Enzymes' suite of protein processing and modification alongside grain and fruit processing in Europe.
Nov-2022: Chr. Hansen and CP Kelco, a nature-based ingredient solutions company, announced a partnership to deliver enhanced consumer-friendly, plant-derived, and long-life yogurt substitutes. With this partnership, CP Kelco's expertise in delivering natural ingredient-based products would boost Chr. Hansen opts for the right culture for the fermentation processes of recipes producing highly nutritious, tasteful, and shelf-stable vegurts.
Jul-2022: Novozymes introduced Innova Apex and Innova Turbo. The two new advanced yeasts are intended to break down fermentation bottlenecks and at the same time decrease the demand for urea and improve ethanol yield. The yeasts maximize the fermentation process, thereby enabling ethanol producers to achieve their production targets. The Innova Apex pushes the plant to 36 & dry solids and decreases glycerol by 38%.
Apr-2022: Chr. Hansen introduced the VEGA™ SAFEPRO® lineup, a new solution developed to maintain plant-derived proteins protected and fresh for a longer time. The new range would incorporate three cultures applicable in fermentation processes providing growth of yeast to empower producers in mitigation of the sodium content in their products while keeping the shelf stability for a longer period.
Apr-2020: Biocatalysts released an animal-free substitute to pancreatic lipase, a porcine enzyme utilized in food processing- Lipomod 888MDP. The new offering would be a non-genetical modified formulation, developed from a fungal preparation.
Nov-2018: AB Enzymes, a subsidiary of Associated British Foods PLC, came into partnership with Spedition Bode, a transportation and logistics services provider, to set up a new warehouse, and strengthen AB Enzymes' position in distributing product samples. With this partnership, Spedition Bode would provide aid to AB Enzymes in boosting AB Enzymes' supply chain across the globe. Moreover, Bode's capabilities in logistics would be leveraged by AB Enzymes in accessing an extensive range of warehousing services.
Market Segments covered in the Report:
By Application
By Form
By Source
By Geography
Companies Profiled
Unique Offerings from KBV Research